GlassScriptPhysician profile
Arshad A Khan
NPI 1114977907
$36,286.60
in general payments reported to CMS, 2019-2025
22 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,388 · 2020: $715 · 2021: $1,299 · 2022: $7,181 · 2023: $17K · 2024: $6,118 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,525 · Travel and Lodging: $3,037 · Food and Beverage: $1,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,222.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,525.00 |
| Travel and Lodging | $3,036.54 |
| Food and Beverage | $1,919.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $17,208.72 | 2019-2023 | Truelok |
| Bioventus LLC | $13,390.96 | 2022-2025 | Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Checkpoint Surgical, INC | $2,807.64 | 2019-2020 | |
| Bioness INC | $403.60 | 2020 | |
| Si-Bone, INC. | $360.16 | 2019-2025 | |
| Medtronic, INC. | $289.88 | 2021-2024 | Intellis Adaptivestim |
| Wright Medical Technology, INC. | $278.95 | 2019 | |
| Nevro Corp. | $270.78 | 2019-2022 | |
| Stryker Corporation | $217.47 | 2019-2021 | |
| Axogen | $189.25 | 2019-2023 | Avance Nerve Graft |
| Convatec INC. | $154.21 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $123.16 | 2022 | |
| Genzyme Corporation | $117.02 | 2024 | |
| Davol INC. | $100.23 | 2021 | |
| Integra Lifesciences Corporation | $86.19 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $72.52 | 2023 | Repatha |
| Radius Health, INC. | $66.24 | 2019-2023 | Tymlos |
| Inspire Medical Systems, INC. | $56.02 | 2023 | Inspire |
| Balt USA, LLC | $47.32 | 2021 | |
| Grt US Holding, INC. | $16.82 | 2022 | |
| Biogen, INC. | $15.34 | 2021 | |
| Redhill Biopharma INC. | $14.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.